Our Pricing

Getting Your 5th Dose from Mounjaro Pen: UK Pharmacist Guide

Many UK patients ask about getting the 5th dose from Mounjaro pen supplies after noticing leftover medication in their KwikPen. At Cured Pharmacy, our clinical team frequently addresses this question, as understanding your pen's capacity can help you maximise treatment value whilst maintaining safe injection practices.

Understanding Mounjaro KwikPen Capacity and Design

The Mounjaro KwikPen is manufactured to deliver four complete doses of your prescribed strength, whether that's 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, or 15mg [1]. Each pen contains slightly more medication than the labelled four doses to account for priming requirements and manufacturing tolerances, which is standard practice across injectable medications regulated by the MHRA.

This overfill exists primarily to ensure accurate delivery of the four intended doses, not specifically to provide a fifth injection. However, the residual medication has led many patients to explore whether an additional dose can be safely extracted. Clinical evidence shows that tirzepatide, the active ingredient in Mounjaro, demonstrated average body weight reductions of 20.9% at the 15mg dose over 72 weeks in the SURMOUNT-1 trial [1], making consistent dosing crucial for optimal outcomes.

The pen's mechanical design uses a spring-loaded mechanism that advances with each click of the dose selector. After four standard doses, the selector may still advance, indicating residual medication remains in the cartridge. Understanding this mechanism is essential before attempting to extract any additional doses, as inconsistent dosing may affect your treatment progression and clinical results.

Step-by-Step Guide to Getting the 5th Dose from Mounjaro Pen

To extract the fifth dose, attach a new needle to your Mounjaro pen following the standard procedure outlined in the patient information leaflet. Turn the dose selector slowly—you may notice it doesn't reach your full prescribed dose. The selector will stop when the remaining medication is reached, which might be less than your standard dose.

Note the exact dose shown on the selector window. If it displays at least 2.5mg, you can proceed with injection using your usual technique: clean your injection site with an alcohol wipe, pinch the skin, insert the needle at a 90-degree angle, and press the dose button fully until '0' appears in the dose window [2]. Hold the needle in place for 10 seconds to ensure complete delivery before removing.

If the selector shows less than 2.5mg—the minimum therapeutic dose of Mounjaro—do not inject this amount. Subtherapeutic doses may not provide clinical benefit and could disrupt your dosing schedule. Instead, safely dispose of the pen in your sharps container and begin your next pen as scheduled. Always maintain your weekly injection routine, as consistency is crucial for the medication's effectiveness demonstrated in clinical trials [1][3].

Preparation and Safety Checks

Before attempting to extract a fifth dose, ensure you've administered all four standard doses from your pen according to your prescribed schedule. Check the medication window to visually confirm liquid remains—it should appear clear and colourless without particles or cloudiness [2]. If the solution appears discoloured or contains visible particles, do not use the remaining medication and contact your prescribing clinician.

Gather a new sterile needle appropriate for subcutaneous injection, alcohol wipes, and your sharps disposal container. Never reuse needles, as this increases infection risk and may damage the pen mechanism. The MHRA emphasises that all injectable medications must follow proper aseptic technique to prevent contamination and ensure patient safety.

Clinical Considerations and Dosing Accuracy

The pharmacokinetics of tirzepatide show a half-life of approximately 5 days, meaning steady-state concentrations are achieved after 4 weeks of weekly dosing [3]. Missing a dose or taking a subtherapeutic amount can temporarily lower blood levels, potentially affecting appetite suppression and glycaemic control if you're using Mounjaro for type 2 diabetes management.

Some patients report successfully extracting fifth doses ranging from 2.5mg to their full prescribed amount, depending on their dose strength and how much overfill their particular pen contains. Manufacturing variability means not every pen will yield a usable fifth dose. According to pharmaceutical manufacturing standards, overfill typically ranges from 5-10% of stated volume, which translates differently across Mounjaro's dose strengths [4].

Impact on Treatment Outcomes

Mounjaro's clinical efficacy depends on consistent, accurate dosing at your prescribed strength. The SURMOUNT trials demonstrated that tirzepatide's dual GIP/GLP-1 receptor agonist mechanism produces dose-dependent weight loss, with higher doses yielding greater reductions [1]. Introducing variable doses—particularly if your fifth dose is substantially less than your prescribed amount—may affect your treatment trajectory.

If you successfully extract a fifth dose that matches your prescribed strength, this essentially provides an additional week of treatment from a four-dose pen. However, if the fifth dose is partial, you'll need to decide whether to supplement it with medication from your next pen or skip to maintain your schedule. Our clinical team at Cured Pharmacy recommends discussing any dosing variations with your prescriber to ensure your treatment plan remains optimised.

Cost Implications and Value Maximisation

At Cured Pharmacy, Mounjaro is available from £135.00, with pricing varying by prescribed dose strength. Successfully extracting a fifth dose from each pen could theoretically extend your supply by 25%, representing significant savings over a long-term treatment course. For patients on higher maintenance doses like 10mg or 15mg, this potential saving becomes increasingly meaningful.

However, cost considerations must be balanced against clinical appropriateness. If attempting to extract a fifth dose leads to wasted medication, injection errors, or inconsistent dosing that compromises your results, the financial benefit diminishes. Our superintendent pharmacist, Tarun Kumar (GPhC 2233073), advises that treatment value should be measured by clinical outcomes rather than dose extraction alone.

Patients should also consider that not every pen will yield a usable fifth dose. If you base your medication ordering on the assumption of five doses per pen and some pens only provide four complete doses, you risk running out of medication between prescriptions. We recommend maintaining your standard four-dose-per-pen calculation for prescription planning, treating any successful fifth dose as a bonus rather than a guaranteed supply extension.

For those seeking to optimise treatment costs, Cured Pharmacy offers transparent upfront pricing with no hidden consultation fees. Our UK-registered prescribers provide free clinical assessments, and we guarantee the lowest prices for genuine UK-licensed Mounjaro in the UK. All patients receive discreet packaging and can access ongoing clinical support throughout their weight management journey.

Safety Precautions and When to Avoid the Fifth Dose

Never force the dose selector beyond its natural stopping point, as this may damage the pen mechanism and deliver an inaccurate dose or cause the pen to malfunction. If the selector feels stuck or doesn't move smoothly, do not attempt to inject. The pen's mechanical integrity is essential for accurate dose delivery, and any compromise could result in over- or under-dosing.

Patients with a history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 should not use Mounjaro at any dose, as tirzepatide carries a boxed warning regarding thyroid C-cell tumours observed in animal studies [2]. Additionally, those with severe gastrointestinal disease, including gastroparesis, should exercise caution, as GLP-1 receptor agonists slow gastric emptying.

If you're unsure about the safety or appropriateness of extracting a fifth dose based on your individual circumstances, contact the clinical team at Cured Pharmacy on (+44) 116 4646009. Our UK-registered prescribers can provide personalised guidance based on your medical history and current treatment response. Never adjust your Mounjaro dosing without professional consultation, as this is a prescription-only medication requiring ongoing clinical oversight.

Contraindications and Warning Signs

Do not attempt to extract a fifth dose if your pen has been stored improperly at any point. Mounjaro must be refrigerated at 2-8°C before first use and can be kept at room temperature (not exceeding 30°C) for up to 21 days after initial use [2]. Temperature excursions may degrade tirzepatide, rendering any remaining medication ineffective or potentially harmful.

Avoid using residual medication if you've experienced any adverse reactions during your current pen's use, such as severe gastrointestinal symptoms, signs of pancreatitis (severe abdominal pain radiating to the back), or allergic reactions. The most common side effects reported in clinical trials include nausea (occurring in up to 29% of patients), diarrhoea, and vomiting, typically decreasing over time [1][3]. If these symptoms have been severe, consult your prescriber before continuing treatment.

Alternative Weight Loss Treatments at Cured Pharmacy

For patients seeking non-injectable alternatives, oral medications like Orlistat work through a completely different mechanism by blocking fat absorption in the digestive system. Orlistat is available in prescription strength (120mg) or lower-dose over-the-counter formulations like Alli (60mg) and Orlos. These medications require commitment to a reduced-fat diet and may cause gastrointestinal side effects if dietary fat intake is too high.

Mysimba tablets combine naltrexone and bupropion to reduce appetite and food cravings through central nervous system pathways. This oral option suits patients who cannot or prefer not to use injectable medications. Clinical trials demonstrated average weight loss of 8.1% over 56 weeks with Mysimba combined with lifestyle modifications [7].

All prescription weight loss medications available through Cured Pharmacy require a free online clinical assessment by our UK-registered prescribers. The assessment takes under three minutes and ensures the selected treatment is safe and appropriate for your individual circumstances. Our clinical team considers your medical history, current medications, weight loss goals, and any previous treatment responses to recommend the most suitable option.

Genuine UK-licensed medications are dispensed from our GPhC-registered pharmacy (9012511) with discreet packaging and reliable delivery. We never supply unlicensed or counterfeit products, ensuring you receive the same quality medications available through traditional UK pharmacies. For questions about which weight loss treatment might be right for you, our team is available to provide expert guidance tailored to your needs.

Comparing Injectable GLP-1 Medications

If you're finding Mounjaro pens don't consistently provide a fifth dose or you're seeking alternative options, Cured Pharmacy offers several other MHRA-licensed weight loss treatments. Wegovy (semaglutide) is a once-weekly injectable that works through GLP-1 receptor activation alone, demonstrating average weight loss of 14.9% over 68 weeks in the STEP 1 trial [5]. Whilst this is lower than Mounjaro's results, Wegovy may be more accessible for some patients and follows a different dose escalation schedule.

Saxenda (liraglutide) offers a daily injection option for those who prefer more frequent, lower-volume injections. As an earlier-generation GLP-1 receptor agonist, Saxenda has an established safety profile and may suit patients who have previously used this medication or who prefer the flexibility of daily dosing. Clinical trials showed average weight loss of 8% over 56 weeks with Saxenda [6].

Scientific References

1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
2. Eli Lilly and Company. (2023). Mounjaro 2.5 mg solution for injection in pre-filled pen: Summary of Product Characteristics. Electronic Medicines Compendium. https://www.medicines.org.uk/emc/product/14269
3. Frias, J. P., Davies, M. J., Rosenstock, J., et al. (2021). Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine, 385(6), 503–515. https://doi.org/10.1056/NEJMoa2107519
4. Medicines and Healthcare products Regulatory Agency. (2021). Guidance on overfill requirements for injectable medicines. GOV.UK. https://www.gov.uk/guidance/injectable-medicines-overfill
5. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
6. Pi-Sunyer, X., Astrup, A., Fujioka, K., et al. (2015). A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine, 373(1), 11–22. https://doi.org/10.1056/NEJMoa1411892
7. Greenway, F. L., Fujioka, K., Plodkowski, R. A., et al. (2010). Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. The Lancet, 376(9741), 595–605. https://doi.org/10.1016/S0140-6736(10)60888-4

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication or adjusting your prescribed dosing schedule.